Barclays PLC Humacyte, Inc. Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Barclays PLC holds 236,742 shares of HUMA stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
236,742
Previous 236,742
-0.0%
Holding current value
$1.1 Million
Previous $1.29 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HUMA
# of Institutions
150Shares Held
35.1MCall Options Held
279KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$33.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$23.5 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$22.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$9.47 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.88 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $478M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...